While historically criticized for inconsistency or opacity, the House Ethics Committee appears to be moving toward a more active and transparent enforcement posture. Last week, the Committee adopted two reports finding Rep. Alexandria Ocasio-Cortez (D-NY) and Rep. Mike Kelly (R-PA) violated House ethics rules. The reports together serve as a warning—both to Members of Congress
Italian Garante Adopts Statement on Health Data and AI
On July 30, 2025, the Italian Data Protection Authority (“Garante”) released a statement addressing the risks of using AI to interpret medical data. In this statement, the Garante recognizes the growing trend of individuals uploading medical analyses, X-rays, and other reports onto generative artificial intelligence platforms to obtain interpretations and diagnoses. It warns users of
FAR Overhaul: OMB Sends 16 Legislative Proposals to Congress, Pushing Sweeping Acquisition Reform
The Office of Management and Budget (OMB) has taken the next major step toward implementing the General Services Administration’s (“GSA”) Revolutionary FAR Overhaul (RFO), submitting to Congress 16 legislative proposals aimed at modernizing federal acquisition law and easing statutory burdens on both agencies and contractors on July 16, 2025. The proposals, published here, underscore
Status of Section 232 Actions by the Trump Administration
Since taking office in January, President Trump has taken a number of actions under Section 232 of the Trade Expansion Act of 1962 (“Section 232”), a statute that authorizes the President to “adjust” imports—including through application of tariffs, quotas, tariff rate quotas, and license fees—where the Department of Commerce (“Commerce”) determines imports threaten to impair U.S.
MHRA Announces Consultation Response on Reforms to GB Pre-Market Medical Device Regulation
On 22 July 2025, the UK Medicines and Healthcare products Regulatory Agency (“MHRA”) published the outcome of its most recent medical device-related consultation. The MHRA also announced its intention to consult further on the indefinite recognition of CE-marked medical devices in Great Britain, with this consultation expected to take place later in 2025.
AI Office Publishes Final Version of the Code of Practice for General-Purpose AI Models
On July 10, 2025, the AI Office published the final version of the Code of Practice for General-Purpose AI Models (the “Code”). The Code is a voluntary compliance tool designed to help companies comply with the AI Act obligations for providers of general-purpose AI (“GPAI”) models. The AI Office and the AI Board will now
FTC Declares July as “Made in the USA” Month
With the Trump administration’s renewed focus on American manufacturing, FTC Chairman Andrew N. Ferguson’s recent declaration that July 2025 is “Made in the USA” Month appears to signal a renewed emphasis on Made in USA enforcement. The FTC has a long history of scrutinizing these claims and the more recently-issued Made in USA Rule sets strict
Fifth Circuit Adopts a Test for Standing at Class Certification Stage
On July 17, 2025, the Fifth Circuit adopted a test for determining whether class plaintiffs meet the Article III injury-in-fact requirement for standing, resolving an open question in the Circuit. Wilson v. Centene Mgmt. Co., L.L.C., No. 24-50044, 2025 WL 1981287 (5th Cir. July 17, 2025).
U.S. Food Agencies Issue Joint Request for Information on Ultra-Processed Foods
On July 25, 2025, the Food and Drug Administration (FDA), the Department of Health and Human Services (HHS), and the United States Department of Agriculture (USDA) issued a joint Request for Information (RFI) seeking “data and information to help develop a uniform definition of ultra-processed foods (UPF or UPFs) for human food products in the
California Attorney General Announces $1.55M CCPA Settlement with Healthline.com
On July 1, 2025, California Attorney General Bonta announced a $1.55 million settlement, pending court approval, related to allegations that Healthline.com, a website where consumers can read informational articles about medical and health topics, violated the California Consumer Privacy Act (“CCPA”) and the California Unfair Competition Law.